Prime Medicine Inc — Balance Sheet (NASDAQ:PRME) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Total assets 360.31 M193.85 M297.51 M Total liabilities 44.04 M60.78 M144.36 M Total equity 316.27 M133.07 M153.15 M Total liabilities & shareholders' equities 360.31 M193.85 M297.51 M Total debt ——— Net debt ———

Nachrichten

Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates

Prime Drink Group schließt erste Tranche der Privatplatzierung ab

Prime Drink Group completes first closing of private placement

Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond

Prime Drink Group plant Privatplatzierung von bis zu 5 Millionen Dollar

Prime Drink Group announces private placement to raise up to $5 million

Goldman Sachs bestätigt Rating für Prime Medicine nach Update zur Strategie bei Morbus Wilson

Goldman Sachs reiterates Early-Stage Biotech rating on Prime Medicine stock

Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates

Prime Medicine appoints Matthew Hawryluk as chief business officer

NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates

Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now (PRME)